New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 23, 2013
12:59 EDTTSROTESARO weakness a buying opportunity, says Mizuho
Mizuho believes TESARO weakness following missed secondary endpoints in Ph. III rolapitant trials is an over-reaction and a buying opportunity. The analyst does not believe the missed secondary endpoints are a major focus of physicians or product success.
News For TSRO From The Last 14 Days
Check below for free stories on TSRO the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 7, 2014
07:27 EDTTSROAmerican Association of Cancer Research to hold annual meeting
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use